Auditory function after continuous infusion of gentamicin to high-risk newborns.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Auditory function after continuous infusion of gentamicin to high-risk newborns. / Colding, H; Andersen, E A; Prytz, S; Wulffsberg, H; Andersen, G E.

I: Acta Paediatrica Scandinavica, Bind 78, Nr. 6, 1989, s. 840-3.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Colding, H, Andersen, EA, Prytz, S, Wulffsberg, H & Andersen, GE 1989, 'Auditory function after continuous infusion of gentamicin to high-risk newborns.', Acta Paediatrica Scandinavica, bind 78, nr. 6, s. 840-3.

APA

Colding, H., Andersen, E. A., Prytz, S., Wulffsberg, H., & Andersen, G. E. (1989). Auditory function after continuous infusion of gentamicin to high-risk newborns. Acta Paediatrica Scandinavica, 78(6), 840-3.

Vancouver

Colding H, Andersen EA, Prytz S, Wulffsberg H, Andersen GE. Auditory function after continuous infusion of gentamicin to high-risk newborns. Acta Paediatrica Scandinavica. 1989;78(6):840-3.

Author

Colding, H ; Andersen, E A ; Prytz, S ; Wulffsberg, H ; Andersen, G E. / Auditory function after continuous infusion of gentamicin to high-risk newborns. I: Acta Paediatrica Scandinavica. 1989 ; Bind 78, Nr. 6. s. 840-3.

Bibtex

@article{bf670b50b55211ddb04f000ea68e967b,
title = "Auditory function after continuous infusion of gentamicin to high-risk newborns.",
abstract = "Audiometry was performed at four years of age in 69 of 105 surviving children who had received continuous intravenous infusion of gentamicin during neonatal intensive care. A hearing loss of 20 dB was found in 2 of them (3%), corresponding to that shown in other studies of survivors following neonatal intensive care. Free field audiometry performed in another 7 children and questionnaires returned from 13 of the remaining 29 gave no suspicion of hearing loss. Thus there is no indication that continuous 24 hours intravenous infusion of gentamicin causes more hearing impairment than intermittent intravenous or intramuscular administration.",
author = "H Colding and Andersen, {E A} and S Prytz and H Wulffsberg and Andersen, {G E}",
note = "Keywords: Audiometry; Auditory Threshold; Follow-Up Studies; Gentamicins; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Neonatal",
year = "1989",
language = "English",
volume = "78",
pages = "840--3",
journal = "Acta Paediatrica Scandinavica",
issn = "0001-656X",
publisher = "Wiley",
number = "6",

}

RIS

TY - JOUR

T1 - Auditory function after continuous infusion of gentamicin to high-risk newborns.

AU - Colding, H

AU - Andersen, E A

AU - Prytz, S

AU - Wulffsberg, H

AU - Andersen, G E

N1 - Keywords: Audiometry; Auditory Threshold; Follow-Up Studies; Gentamicins; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Neonatal

PY - 1989

Y1 - 1989

N2 - Audiometry was performed at four years of age in 69 of 105 surviving children who had received continuous intravenous infusion of gentamicin during neonatal intensive care. A hearing loss of 20 dB was found in 2 of them (3%), corresponding to that shown in other studies of survivors following neonatal intensive care. Free field audiometry performed in another 7 children and questionnaires returned from 13 of the remaining 29 gave no suspicion of hearing loss. Thus there is no indication that continuous 24 hours intravenous infusion of gentamicin causes more hearing impairment than intermittent intravenous or intramuscular administration.

AB - Audiometry was performed at four years of age in 69 of 105 surviving children who had received continuous intravenous infusion of gentamicin during neonatal intensive care. A hearing loss of 20 dB was found in 2 of them (3%), corresponding to that shown in other studies of survivors following neonatal intensive care. Free field audiometry performed in another 7 children and questionnaires returned from 13 of the remaining 29 gave no suspicion of hearing loss. Thus there is no indication that continuous 24 hours intravenous infusion of gentamicin causes more hearing impairment than intermittent intravenous or intramuscular administration.

M3 - Journal article

C2 - 2603707

VL - 78

SP - 840

EP - 843

JO - Acta Paediatrica Scandinavica

JF - Acta Paediatrica Scandinavica

SN - 0001-656X

IS - 6

ER -

ID: 8670129